PrEParing: PrEP for Providers and Patients

Pre-Exposure Prophylaxis (PrEP) using the antiretroviral medication emtricitibine/tenofovir approved in countries around the world is a highly effective means of reducing transmission of HIV through sexual encounters and needle sharing.

This Johns Hopkins University course PrEPares you with essential information, concepts and practical advice regarding PrEP from leaders in the field. A first of its kind learning opportunity, both providers and patients learn from the same experts through content that meets the needs of both audiences, while facilitating the opportunity for a shared community space.

Lessons for healthcare workers provide background on foundational and cutting-edge research and PrEP guidelines, how to initiate a PrEP program, clinical management and providing culturally sensitive sexual health and primary care to diverse communities.

Lessons for PrEP enthusiasts, PrEP users or the PrEP curious provide information regarding who can benefit from PrEP, how to access services, what to expect and how to stick with your PrEP program long-term.

OBJECTIVES:

At the conclusion of the session, the participant will be able to:

1. Describe the differences between foundational PrEP studies and demonstration projects

2. Describe the basic pharmacodynamics of tenofovir/emtricitibine including mechanism of infection prevention and time

to protective concentration in mucosal tissues

3. List recommendations from PrEP for Prevention of HIV Infection in the United States clinical practice guidelines, USPHS

and CDC, including initial and ongoing screening and testing

4. Describe the need for PrEP as an HIV prevention tool for priority in often stigmatized populations

5. Indicate the components for integrating PrEP services into clinical practice

6. Outline guidelines for screening and treatment of sexually transmitted infections

7. Describe how to take a thorough sexual history and to engage with clients around sex in an affirming and non-

judgmental manner

8. List the baseline and follow-up laboratory monitoring required

9. Explain key aspects of patient education for HIV prevention and sexual health

10. Describe protocols for ongoing PrEP services and when to discontinue

FACULTY/ CREDENTIALS:

Jason E. Farley, PhD, MPH, ANP-BC, FAAN, Associate Professor

Johns Hopkins University School of Nursing

Chris Beyrer, MD, MPH, Professor

Johns Hopkins University Bloomberg School of Public Health

Yusuf Ariyibi, BA, Disease Intervention Specialist

Baltimore City Health Department

Joyce Jones, MD, MS, Clinical Associate

Johns Hopkins University School of Medicine

Neha Sheth Pandit, PharmD, AAHIVP, BCPS, Associate Professor

University of Maryland School of Pharmacy

Pierre-Cedric Crouch, PhD, ANP-BC, ACRN, Director of Nursing

San Francisco AIDS Foundation

Renata Arrington Sanders, MD, Assistant Professor

Johns Hopkins University School of Medicine

Jenell Coleman, MD, MPH, Associate Professor

Johns Hopkins University School of Medicine

Michele Decker, ScD, MPH, Associate Professor

Johns Hopkins University Bloomberg School of Public Health

Deborah Dunn, PA-C, MBA, Physician Assistant

Chase Brexton Health Care

Jordan White, MS, Desmond Tutu Fellow of Public Health and Human Rights

Johns Hopkins University Bloomberg School of Public Health

Gregory Lucas, MD, PhD, Professor

Johns Hopkins University School of Medicine

Demetre Daskalakis, MD, MPH, Acting Deputy Commissioner, Division of Disease Control, NYC Dept. of Health and Mental Hygiene

David Dowdy, MD, PhD, Associate Professor

Johns Hopkins University Bloomberg School of Public Health

Jessica LaRicci, PrEP Coordinator

Johns Hopkins University School of Nursing

Susan Tuddenham, MD, MPH, Assistant Professor

Johns Hopkins University School of Medicine

Joseph Cofrancesco, MD, MPH, FACP, Associate Professor of Medicine

Johns Hopkins University School of Medicine

Jill Crank, CRNP, MSN/MPH, Nurse Practitioner

Evergreen Healthcare

Paul Sacaman